Breast Cancer Prevention: Raloxifene as Effective as Tamoxifen with Fewer Side Effects

	Tweet

In an update of the 19,490-patient Study of Tamoxifen and Raloxifene (STAR) P-2 trial in breast cancer prevention, both raloxifene and tamoxifen remain effective options to prevent breast cancer at 81 months of follow-up.

Raloxifene improved its effectiveness against noninvasive breast cancer, caused significantly less endometrial cancer and was significantly less toxic than tamoxifen. Although it was slightly less effective against invasive breast cancer, it still maintained strong efficacy.

Due to the late-breaking nature of these data, full results are being withheld until the trial is presented at the American Association for Cancer Research 101st Annual Meeting 2010 during a special plenary session in Hall D of the Walter E. Washington Convention Center at 10:00 a.m. ET on Monday, April 19, 2010. These results will be published simultaneously in Cancer Prevention Research, a journal of the AACR. 

A panel of experts will be available to take questions from the media in room 142 of the convention center at 11:00 a.m. ET on April 19. Reporters who cannot attend in person can participate by calling in, using the following information:

U.S. and Canada: (888) 282-7404
International: (706) 679-5207
Access Code: 67263212

Download interviews with cancer researchers and recordings of the teleconferences by subscribing to the AACR Scientific Podcasts via iTunes (http://www.aacr.org/itunes) or an RSS Reader (http://www.aacr.org/rss).

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 31,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowship and career development awards. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.

Source:  American Association for Cancer Research (AACR)

RELATED STORIES:
Why Do Some Women Develop Breast Cancer Earlier Than Others?   BRCA Mutations Among Asian-American Women May be More Common Than Predicted   Scientists unravel breast cancer risk gene mystery   Large breast cancers persist despite screening   Many Women Who Had Childhood Cancer Do Not Undergo Breast Cancer Screening   V. Suzanne Klimberg, M.D. Authors Book on Breast Surgical Techniques   Radiotherapy delay ups risk of breast cancer return   Radiation fears should not deter women from mammography screening   Breast conserving surgery is a good option for early breast cancer   Metabolic syndrome predicts breast cancer relapse   Scientists Discover Cancer-causing Role of Gene Proteins   New MRI Technique Could Mean Fewer Breast Biopsies in High-Risk Women   MU Researchers Recommend Exercise for Breast Cancer Survivors, Lymphedema Patients   No long-term cancer risk seen from breast implants   What should be the goal of treatment in metastatic breast cancer?   Expanding cell girth indicates seriousness of breast cancer   Berkeley Lab Scientists Find that Normal Breast Cells Help Kill Cancer Cells   Inflammatory Breast Cancer More Rare, More Lethal than Common Form   Breast Cancer Not Just a Woman’s Disease   University of Arkansas to Host National Breast Cancer Workshop   Extra Radiation Dose Prevents Breast Cancer Return in Young Women   Stress Linked To How Aggressive A Breast Cancer Might Be

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]